Tg Therapeutics (TGTX) Return on Equity: 2016-2025
Historic Return on Equity for Tg Therapeutics (TGTX) over the last 9 years, with Sep 2025 value amounting to 1.01%.
- Tg Therapeutics' Return on Equity rose 109.00% to 1.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.01%, marking a year-over-year increase of 109.00%. This contributed to the annual value of 0.12% for FY2024, which is 1.00% up from last year.
- Latest data reveals that Tg Therapeutics reported Return on Equity of 1.01% as of Q3 2025, which was up 330.32% from 0.24% recorded in Q2 2025.
- Tg Therapeutics' Return on Equity's 5-year high stood at 1.01% during Q3 2025, with a 5-year trough of -6.01% in Q2 2023.
- Over the past 3 years, Tg Therapeutics' median Return on Equity value was 0.11% (recorded in 2024), while the average stood at -0.80%.
- Per our database at Business Quant, Tg Therapeutics' Return on Equity surged by 950bps in 2021 and then slumped by 406bps in 2023.
- Quarterly analysis of 5 years shows Tg Therapeutics' Return on Equity stood at -1.28% in 2021, then plummeted by 160bps to -2.87% in 2022, then surged by 295bps to 0.08% in 2023, then grew by 3bps to 0.11% in 2024, then spiked by 109bps to 1.01% in 2025.
- Its Return on Equity was 1.01% in Q3 2025, compared to 0.24% in Q2 2025 and 0.17% in Q1 2025.